Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
If a patient has not shown at least a 2-point reduction in VAS pain score by week 6, the protocol should be reassessed
This can help prevent chronic diseases such as heart disease, cancer, and neurodegenerative disorders
In the same assay it is 200 times as potent as aminoglutethimide (AG), twice as potent as 4-OHA and one third as potent as Fadrozole [1]
We need to improve access to these medications
Use local knee injection when: - You have a specific, localized injury (torn ACL, MCL sprain, patellar tendinopathy, meniscus tear) - Pain concentrates in one area of the knee - You can identify the approximate location of the damaged structure Use systemic injection when: - You have diffuse knee pain without a clear source - Multiple structures are involved (post-surgical, advanced osteoarthritis) - You are stacking BPC-157 with TB-500 for broader systemic repair - You cannot tolerate injections near the knee Split protocol: Some users inject 60-70% of their daily dose locally near the knee and the remaining 30-40% subcutaneously in the abdomen
